MapLight Therapeutics (MPLT) Cash from Financing Activities (2024 - 2025)
MapLight Therapeutics (MPLT) reported Cash from Financing Activities of $272.0 million for Q4 2025, up 5439200.0% on a YoY basis from N/an in Q4 2024, and up 5439200.0% sequentially from $5000.0 in Q4 2024.
MapLight Therapeutics (MPLT) Cash from Financing Activities (2024 - 2025) Analysis & Trends
MapLight Therapeutics (MPLT) has 2 years of Cash from Financing Activities data on file, last reported at $272.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | MapLight Therapeutics | 305.82 Mn | 305.82 Mn | - | 271.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 271.97 Mn |
| Dec 31, 2025 | 271.97 Mn |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |